World's Best Scientists 2026 revealed!
Paul Rutgeerts

Paul Rutgeerts

Award Badge
Best Scientists
2025
Award Badge
Medicine
Belgium
2023

D-Index & Metrics

Best Scientists

D-Index
180
Citations
149623
World Ranking
611
National Ranking
4

Medicine

D-Index
183
Citations
153968
World Ranking
323
National Ranking
4

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in Belgium Leader Award
  • 2022 - Research.com Medicine in Belgium Leader Award

Overview

Paul Rutgeerts was affiliated with KU Leuven in Belgium and engaged in research predominantly within the fields of Biochemistry, Genetics and Molecular Biology as well as Medicine. Their work spanned several subfields including Molecular Biology, Physiology, Biophysics, Materials Chemistry, and Oncology.

Research topics explored by Rutgeerts encompassed:

  • Photochromic and Fluorescence Chemistry
  • RNA and protein synthesis mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Calcium signaling and nucleotide metabolism
  • PARP inhibition in cancer therapy
  • Adenosine and Purinergic Signaling
  • Brain Metastases and Treatment

Rutgeerts contributed to multiple peer-reviewed articles, including notable publications such as:

  • Light-controlled twister ribozyme with single-molecule detection resolves RNA function in time and space, 2020, Proceedings of the National Academy of Sciences
  • Orally Bioavailable Enzymatic Inhibitor of CD38, MK-0159, Protects against Ischemia/Reperfusion Injury in the Murine Heart, 2022, Journal of Medicinal Chemistry
  • Demystifying the Role of Radiation Dose Bath in Brain Injury Using Machine Learning, 2023, International Journal of Radiation Oncology*Biology*Physics
  • BPS2025 - Self-healing fluorophores unveil protein-induced photobleaching mechanisms, 2025, Biophysical Journal
  • Graphene flakes modified carbon paste electrode as a sensitive electrochemical sensor for the quantification of dopamine agonist drug pramipexole in biological samples, 2025, Electrochimica Acta

Their frequent co-authors included Arthur Korman, Huabing Sun, Boyang Hua, Haozhe Yang, and Joseph N. Capilato.

Rutgeerts published in journals with a diverse range of focus, such as:

  • Proceedings of the National Academy of Sciences
  • Journal of Medicinal Chemistry
  • International Journal of Radiation Oncology*Biology*Physics
  • Biophysical Journal
  • Electrochimica Acta

Best Publications

  • Infliximab for induction and maintenance therapy for ulcerative colitis.

    Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

  • Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

    Jean Frédéric Colombel;William J. Sandborn;Walter Reinisch;Gerassimos J. Mantzaris

  • Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

    Jeffrey C. Barrett;Sarah Hansoul;Dan L. Nicolae;Judy H. Cho

  • Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang

  • Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.

    Filip Baert;Maja Noman;Severine Vermeire;Gert Van Assche

  • Vedolizumab as induction and maintenance therapy for ulcerative colitis.

    Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

  • Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

    Bruce E. Sands;Frank H. Anderson;Charles N. Bernstein;William Y. Chey

  • Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

    Jean–Frédéric Colombel;William J. Sandborn;Paul Rutgeerts;Robert Enns

  • Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    William J. Sandborn;Brian G. Feagan;Paul Rutgeerts;Stephen Hanauer

  • Predictability of the postoperative course of Crohn's disease

    Paul Rutgeerts;Karel Geboes;Gaston Vantrappen;J Beyls

  • A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

    Kathleen Machiels;Marie Joossens;João Sabino;Vicky De Preter

  • Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

    Stephen B. Hanauer;William J. Sandborn;Paul Rutgeerts;Richard N. Fedorak

  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

    Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke

  • Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

    Marco Daperno;Geert D'Haens;Gert Van Assche;Filip Baert

  • A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

    Geert D’Haens;William J. Sandborn;Brian G. Feagan;Karel Geboes

  • Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test

    Yvo F. Ghoos;Bart D. Maes;Benny J. Geypens;Geert Mys

  • Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    William J. Sandborn;Christopher Gasink;Long Long Gao;Marion A. Blank

  • Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

    Gert Van Assche;Marc Van Ranst;Raphael Sciot;Bénédicte Dubois

  • Laboratory markers in IBD: useful, magic, or unnecessary toys?

    S Vermeire;G Van Assche;P Rutgeerts

  • Early Lesions of Recurrent Crohn's Disease Caused by Infusion of Intestinal Contents in Excluded Ileum

    Geert R. D'Haens;Karel Geboes;Mark Peeters;Filip Baert

Frequent Co-Authors

William J. Sandborn
William J. Sandborn University of California, San Diego
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Walter Reinisch
Walter Reinisch Medical University of Vienna
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Jan Ceuppens
Jan Ceuppens KU Leuven
Marc Peeters
Marc Peeters University of Antwerp
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, a variety of online degree options can help broaden your opportunities in the healthcare field. For those interested in mental health, the shortest pmhnp program offers an accelerated path to becoming a Psychiatric Mental Health Nurse Practitioner, enabling faster entry into a high-demand specialty.

Healthcare leadership is another growing area. Online healthcare administration programs prepare students for management positions in hospitals, clinics, and other organizations. If you’re aiming even higher, a master's in healthcare administration online can give you a competitive edge and open doors to executive roles without interrupting your current career.

For advanced clinical practice and leadership, consider exploring dnp online programs cheap. Earning a Doctor of Nursing Practice (DNP) degree online makes it possible to balance study with work and family life, while keeping tuition costs manageable.

These flexible online pathways support diverse goals in healthcare, whether you’re interested in clinical roles, mental health, or healthcare management.

Best Scientists Citing Paul Rutgeerts

Recently Published Articles